Resources
The AMA has collected more than 450 educational and other resources to provide evidence-based recommendations for physicians and policymakers.
The AMA has collected more than 450 educational and other resources to provide evidence-based recommendations for physicians and policymakers.
A new issue brief from the AMA Advocacy Resource Center provides key information about kratom and tianeptine—two unregulated substances that have generated increasing reports of public health harms.
A new issue brief from the American Medical Association providing updates on data, trends and policy directions.
AMA Issue Brief: Help save lives—prescribe and distribute naloxone.
ARC Issue Brief: support medical criteria for medical necessity determinations for mental health and substance use disorders.
The DOL/HHS/IRS 2024 Report to Congress showed that health plans and issuers continue to fail to comply with the Mental Health Parity and Addiction Equity Act of 2008 (MHPAEA) and subsequent Congressional enhancements to MHPAEA. Failures ranged from improper denial of care for mental health and substance use disorders (MH/SUD), inadequate MH/SUD networks, and failure to reimburse MH/SUD providers on par with medical/surgical providers. Read the AMA summary for more detail.
On September 9, 2024, the U.S. Departments of Labor, Health and Human Services, and Treasury released a final rule implementing the Mental Health Parity and Addiction Equity Act (MHPAEA). The 513-page rule includes numerous provisions strongly supported by the AMA and represents an opportunity for state legislatures and departments of insurance to strengthen their own parity laws.
The AMA Substance Use and Pain Care Task Force urges physicians and other health care professions to continue taking action to help reverse the nation’s drug overdose epidemic—and the Task Force also calls on policymakers to take specific steps to remove barriers to evidence-based care for patients with pain and those with a substance use disorder.
Learn More Join the AMA today and help us lead the effort
to reverse the nation’s opioid epidemic.